University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
University of Maryland, School of Medicine, Center for Vaccine Development and Global Health
Baltimore, Maryland, United States3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of Chimeric Hemagglutinin mRNA Vaccine Candidates | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Not yet recruiting | Phase 1 | 2026-10-09 | NCT07703514 | |
| A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults | COVID-19, Coronaviridae Infections, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, RNA Virus Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Recruiting | Phase 1 | 2026-10-09 | NCT07536308 | |
| pH1N1 Blinded Challenge Study | Infections, RNA Virus Infections, influenza, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease | Recruiting | Phase 1 | 2026-10-09 | NCT07110532 |